Proactiv recalls Proactiv and Proactiv + BPO products over benzene level outside allowed limit
The notice says the amount of benzene in Proactiv and Proactiv + BPO products is outside the allowable limit, which it lists as a product safety issue.
What to do
Verify if your product is affected and stop taking the product. Consult your healthcare provider for any health concerns, and contact the recalling firm if you have questions. Report any health product side effects or safety complaints to Health Canada.
Recall details
- Product
- Proactiv / Proactiv + BPO products
- Company
- Proactiv
- Hazard
- Product safety
- Class or risk level
- Type II
- Notice last updated
- November 5, 2025
- Listed on Recalled Today
- November 5, 2025
Recalled Today dates each recall from the day it first appeared in the official data.
The headline, summary and steps above are written in plain English from the official notice below. Identifiers are copied exactly as the agency published them. Always check the official notice before you act.
Official notice
The notice's own wording from Health Canada.
Proactiv / Proactiv + BPO Products: Benzene Concentration Outside Allowable Limit
- Product
- Proactiv / Proactiv + BPO products
- Issue
- Product safety
- What you should do
- Verify if your product is affected. Stop taking the product. Consult your healthcare provider for any health concerns. Contact the recalling firm if you have any questions about the recall. Report any health product related side effects to Health Canada. Report any other health product safety complaints to Health Canada.
- Recall class
- Type II
- Category
- Drugs
- Organization
- Drugs and health products
Contains information licensed under the Open Government Licence – Canada. Open Government Licence
Recalled Today is independent and is not an official government page.
Related recalls
Femyso recalls Mifepristone and Misoprostol tablets over mixed-up cartons in one lot
An affected lot may contain two green Mifepristone cartons or two pink Misoprostol cartons instead of one of each.
Aleve recalls 200 mg caplets from wholesalers over a distribution error
Aleve 200 mg caplets were recalled from wholesalers because of a distribution error, and the notice gives no other details about the problem.
Claritin recalls Claritin Allergy Tablets 10 mg from wholesalers over distribution error
Claritin Allergy Tablets 10 mg are being recalled from wholesalers because of a distribution error, and the notice gives no other details about the problem.
PMS-FAMPRIDINE 10 mg tablets recalled over possible foreign material particles in affected lot
One lot of PMS-FAMPRIDINE 10 mg Tablet may contain foreign material particles.
PMS-Carvedilol recalls 25 mg tablets over impurity level outside the allowed limit
PMS-Carvedilol 25 mg tablets did not meet the product's quality specification because of an impurity.
Carvedilol 25 mg tablets recalled over impurity level outside the allowed limit
Health Canada says Carvedilol 25 mg tablets were found to be out of specification for an impurity, which it lists as a product quality issue.